Related references
Note: Only part of the references are listed.Unmodified drug used as a material to construct nanoparticles: delivery of cisplatin for enhanced anti-cancer therapy
Shutao Guo et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model
Jing Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Lipid-Coated Cisplatin Nanoparticles Induce Neighboring Effect and Exhibit Enhanced Anticancer Efficacy
Shutao Guo et al.
ACS NANO (2013)
A Highly Efficient Synthetic Vector: Nonhydrodynamic Delivery of DNA to Hepatocyte Nuclei in Vivo
Yunxia Hu et al.
ACS NANO (2013)
Engineering the Assemblies of Biomaterial Nanocarriers for Delivery of Multiple Theranostic Agents with Enhanced Antitumor Efficacy
Hai Wang et al.
ADVANCED MATERIALS (2013)
Combinational delivery of c-myc siRNA and nucleoside analogs in a single, synthetic nanocarrier for targeted cancer therapy
Yuan Zhang et al.
BIOMATERIALS (2013)
Systemic delivery of gemcitabine triphosphate via LCP nanoparticles for NSCLC and pancreatic cancer therapy
Yuan Zhang et al.
BIOMATERIALS (2013)
Biocompatible gemcitabine-based nanomedicine engineered by Flow Focusing® for efficient antitumor activity
Lucia Martin-Banderas et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis
Zhenghong Xu et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug
Xiaoyang Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Stimulated Release of Size-Selected Cargos in Succession from Mesoporous Silica Nanoparticles
Cheng Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
Che-Ming Jack Hu et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Synergistic interaction between cisplatin and gemcitabine in neuroblastoma cell lines and multicellular tumor spheroids
Odette G. Besancon et al.
CANCER LETTERS (2012)
Herb-Drug Interactions and Mechanistic and Clinical Considerations
Xiao-Wu Chen et al.
CURRENT DRUG METABOLISM (2012)
Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor
Jun Li et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy
Jason Park et al.
NATURE MATERIALS (2012)
EGFR Targeted PLGA Nanoparticles Using Gemcitabine for Treatment of Pancreatic Cancer
Sahil Aggarwal et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2011)
Polymeric Nanoparticles with Precise Ratiometric Control over Drug Loading for Combination Therapy
Santosh Aryal et al.
MOLECULAR PHARMACEUTICS (2011)
The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers
Carlee E. Ashley et al.
NATURE MATERIALS (2011)
Multifunctional Mesoporous Silica Nanospheres with Cleavable Gd(III) Chelates as MRI Contrast Agents: Synthesis, Characterization, Target-Specificity, and Renal Clearance
Juan L. Vivero-Escoto et al.
SMALL (2011)
Polymer-Caged Nanobins for Synergistic Cisplatin-Doxorubicin Combination Chemotherapy
Sang-Min Lee et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Nanocomposites with Spatially Separated Functionalities for Combined Imaging and Magnetolytic Therapy
Shang-Hsiu Hu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Targeted Intracellular Delivery of Antisense Oligonucleotides via Conjugation with Small-Molecule Ligands
Osamu Nakagawa et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Tumor Tissue-Derived Formaldehyde and Acidic Microenvironment Synergistically Induce Bone Cancer Pain
Zhiqian Tong et al.
PLOS ONE (2010)
Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy
Nagesh Kolishetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Combination therapy: Opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines
Francesca Greco et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Drug ratio-dependent antitumor activity of irinotecan and cisplatin combinations in vitro and in vivo
Paul G. Tardi et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Optimizing combination chemotherapy by controlling drug ratios
Lawrence D. Mayer et al.
MOLECULAR INTERVENTIONS (2007)
Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice
Lawrence D. Mayer et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei
B Liedert et al.
NUCLEIC ACIDS RESEARCH (2006)
Anticancer therapeutics: Addictive targets, multi-targeted drugs, new drug combinations
HJ Broxterman et al.
DRUG RESISTANCE UPDATES (2005)
Gemcitabine potentiates cisplatin cytotoxicity and inhibits repair of cisplatin-DNA damage in ovarian cancer cell lines
MA Moufarij et al.
MOLECULAR PHARMACOLOGY (2003)
PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in Vivo drug residence in blood properties
K Avgoustakis et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Share Paper
